Tirzepatide is a dual GIP/GLP-1 receptor agonist approved under Mounjaro for type 2 diabetes and under Zepbound for chronic weight management and moderate-to-severe obstructive sleep apnea in adults with obesity
Erectile dysfunction and premature ejaculation Hair loss Fertility General health What we like offers both OTC and prescription treatments for a wide variety of health conditions convenient and accessible quick shipping in discreet packaging includes unlimited follow-ups with a healthcare professional What to consider not covered by insurance requires an internet connection and familiarity with technology some medications can be expensive some reports of slow response times, lack of communication, and issues with shipping and billing Ro is for adults who have certain health concerns that can be treated virtually
2 For more details, read our guide on when retatrutide might be available on the NHS
Tirzepatide (Mounjaro, Zepbound) is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, not a pure GLP-1 agent
Although the weight reduction is not as substantial compared with the Tirzepatide or Semaglutide outcomes, dulaglutide still offers significant advantages in improving glycemic control
While GLP-1 drugs can be highly effective for weight loss and diabetes management, they work best as part of comprehensive treatment plans that include dietary changes and physical activity